Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Simmons

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Transfusion|September 2, 2022
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsMaja Weisser, Nina Khanna, Anemone Hedstueck, et al.
Microbiology Spectrum|November 24, 2021
SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent PlasmaJesse D Deere, Timothy D Carroll, Joseph Dutra, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaquesSonny R Elizaldi, Yashavanth Shaan Lakshmanappa, Jamin W Roh, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Biotechnology|April 16, 2021
Generation of recombinant hyperimmune globulins from diverse B-cell repertoiresSheila M Keating, Rena A Mizrahi, Matthew S Adams, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Transfusion|September 2, 2022
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsMaja Weisser, Nina Khanna, Anemone Hedstueck, et al.
Microbiology Spectrum|November 24, 2021
SARS-CoV-2 Infection of Rhesus Macaques Treated Early with Human COVID-19 Convalescent PlasmaJesse D Deere, Timothy D Carroll, Joseph Dutra, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
SARS-CoV-2 infection induces germinal center responses with robust stimulation of CD4 T follicular helper cells in rhesus macaquesSonny R Elizaldi, Yashavanth Shaan Lakshmanappa, Jamin W Roh, et al.
Biorxiv : the Preprint Server for Biology|September 8, 2021
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Plos Pathogens|April 20, 2022
Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammationKoen K A Van Rompay, Katherine J Olstad, Rebecca L Sammak, et al.
Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Nature Biotechnology|April 16, 2021
Generation of recombinant hyperimmune globulins from diverse B-cell repertoiresSheila M Keating, Rena A Mizrahi, Matthew S Adams, et al.
Pageof 13